Order Article Reprints

Toro DM, da Silva-Neto PV, de Carvalho JCS, Fuzo CA, Pérez MM, Pimentel VE, Fraga-Silva TFC, Oliveira CNS, Caruso GR, Vilela AFL, et al. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. Cells. 2023; 12(15):1938. https://doi.org/10.3390/cells12151938

Toro, Diana Mota, Pedro V. da Silva-Neto, Jonatan C. S. de Carvalho, Carlos A. Fuzo, Malena M. Pérez, Vinícius E. Pimentel, Thais F. C. Fraga-Silva, Camilla N. S. Oliveira, Glaucia R. Caruso, Adriana F. L. Vilela, and et al. 2023. "Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19" Cells 12, no. 15: 1938. https://doi.org/10.3390/cells12151938

Toro, D. M., da Silva-Neto, P. V., de Carvalho, J. C. S., Fuzo, C. A., Pérez, M. M., Pimentel, V. E., Fraga-Silva, T. F. C., Oliveira, C. N. S., Caruso, G. R., Vilela, A. F. L., Nobre-Azevedo, P., Defelippo-Felippe, T. V., Argolo, J. G. M., Degiovani, A. M., Ostini, F. M., Feitosa, M. R., Parra, R. S., Vilar, F. C., Gaspar, G. G., ... ImmunoCovid Consortium Group. (2023). Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. Cells, 12(15), 1938. https://doi.org/10.3390/cells12151938